Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 71

    Claris Lifesciences shares to delist on March 22

    Claris Lifesciences shares to delist on March 22

    Ruby Khatun Khatun13 March 2018 9:06 AM IST
    New Delhi: Claris Lifesciences on Monday announced the delisting of Equity shares from the BSE with effect from March 22, 2018, while the...
    Infestation alert: USFDA finds Female Mosquito at Aurobindo Pharma facility

    Infestation alert: USFDA finds Female Mosquito at Aurobindo Pharma facility

    Ruby Khatun Khatun12 March 2018 11:18 AM IST
    New Delhi: US Food and Drug Administration officials found a 'large female mosquito' in a facility of Aurobindo Pharma during the inspection, which,...
    Labeling Norms For Generic Drugs: Health Minister apprises parliament

    Labeling Norms For Generic Drugs: Health Minister apprises parliament

    Ruby Khatun Khatun11 March 2018 11:56 AM IST
    New Delhi: The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about the...
    Health insurer Cigna to buy Express Scripts for about 54 billion dollars

    Health insurer Cigna to buy Express Scripts for about 54 billion dollars

    Ruby Khatun Khatun11 March 2018 9:15 AM IST
    U.S. health insurer Cigna Corp said it would buy pharmacy benefits manager Express Scripts Holding Co for about $54 billion, the latest deal in the...
    Transfer of NPPA head- a move of Industry lobby, allege activists

    Transfer of NPPA head- a move of Industry lobby, allege activists

    Ruby Khatun Khatun10 March 2018 5:02 PM IST
    New Delhi: The chairman of National Pharmaceutical Pricing Authority (NPPA), Bhupendra Singh on 1st March 2018 has been transferred to the National...
    Panacea Biotec gets EIR from USFDA for its Baddi facility

    Panacea Biotec gets EIR from USFDA for its Baddi facility

    Ruby Khatun Khatun10 March 2018 10:55 AM IST
    New Delhi: Drug firm Panacea Biotec said it has received Establishment Inspection Report (EIR) from the US health regulator for its Baddi facility in...
    TOP Private Equity firms in race to buy stake in Mankind Pharma

    TOP Private Equity firms in race to buy stake in Mankind Pharma

    Ruby Khatun Khatun9 March 2018 3:48 PM IST
    Mumbai: Private equity firms Advent International and Carlyle Group have entered into the final stage for Mankind Pharma deal.According to Times of...
    Lupin signs research pact with CSIR-NCL, Dept of Science and Tech

    Lupin signs research pact with CSIR-NCL, Dept of Science and Tech

    Ruby Khatun Khatun9 March 2018 10:05 AM IST
    Mumbai: Pharma major Lupin has signed an agreement with CSIR-National Chemical Laboratory (CSIR-NCL, Pune) and Department of Science and Technology,...
    Major Investor In Manipal Healthcare now looking for Exit: Report

    Major Investor In Manipal Healthcare now looking for Exit: Report

    Ruby Khatun Khatun8 March 2018 2:07 PM IST
    New Delhi: In less than a year, Temasek, a Singapore based sovereign wealth fund is looking to exit Bengaluru based multi-specialty hospital chain...
    DoP invokes Emergency Clause- Directs Manufacturer to maintain HEP C medicine production

    DoP invokes Emergency Clause- Directs Manufacturer to maintain HEP C medicine production

    Ruby Khatun Khatun8 March 2018 9:57 AM IST
    New Delhi: Department of Pharmaceuticals said it has invoked powers under the Drugs Prices Control Order, 2013 to direct Fulfords India to maintain...
    Syringes and needles being sold at 214 to 1251 percent margin: NPPA

    Syringes and needles being sold at 214 to 1251 percent margin: NPPA

    Ruby Khatun Khatun7 March 2018 4:13 PM IST
    New Delhi: NPPA seems to be shifting its focus on syringes and needles, as these medical equipment are being sold at very high margins.The National...
    NPPA fixes prices of 12 formulations including Brufen Plus,Vitamin D3; check out details

    NPPA fixes prices of 12 formulations including Brufen Plus,Vitamin D3; check out details

    Ruby Khatun Khatun6 March 2018 3:41 PM IST
    New Delhi: National drug pricing regulator NPPA said it has fixed the retail/ceiling prices of 12 formulations including those used for the treatment...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok